2 FTSE 100 and FTSE 250 shares I’d consider buying to hold for 5 years!

I believe these FTSE 350 shares could help supercharge my returns over the next several years. Here’s why I’d buy them for my Stocks and Shares ISA.

| More on:
Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m searching for the best FTSE 100 and FTSE 250 shares to buy and hold to the end of the decade. Here are two on my watchlist.

Spire Healthcare Group

The poor state of the National Health Service (NHS) makes Spire Healthcare Group (LSE:SPI) an attractive investment today. Demand for private healthcare is likely to continue rising as patients seek to avoid long waiting lists.

Fresh Office for National Statistics research shows that almost 10m people are either waiting for a hospital appointment or to begin receiving NHS treatment. This backlog will likely take years to cut substantially, a challenge made all the more difficult by the growing healthcare needs of an ageing population.

It’s why I expect demand for Spire’s services from both self-pay patients and those using private medical insurance to keep soaring. Private revenues jumped 9.5% year on year in 2023, to £959.7m which, in turn, pushed operating profit almost a third higher, to £126.2m.

Spire can also expect further business from the NHS to help cut those massive waiting lists. NHS-related revenues leapt 15.5% in 2023, to £341.1m. And Spire has advised that “there could be increased commissioning” further down the line.

Reflecting this bright outlook, City analysts expect annual earnings growth here to average 34% through to 2026. This leaves the FTSE 250 firm trading on a forward price-to-earnings growth (PEG) ratio of 0.8.

Any reading below 1 indicates that a stock is undervalued. Despite the threat of potential staffing shortages, I’m considering adding more Spire shares to my portfolio.

Antofagasta

I also think getting exposure to copper could be a good idea today. Prices of the essential metal just struck 14-month highs of $9,300 a tonne on mounting supply risks. And bets of further rises are growing on hopes of recovering Chinese demand.

Analysts at Citi, for instance, expect copper values to hit $12,000 within the next two years.

Purchasing a copper-backed exchange-traded fund (ETF) could allow me to exploit any further price rises. But I’d rather buy shares in a dividend-paying mining stock. This strategy would also provide me with an income.

Antofagasta (LSE:ANTO) is one such stock to consider buying today. For this year the Chile-focused miner carries a dividend yield of 1.2%, a figure that rises steadily through to 2026.

While some other copper stocks offer larger yields, Antofagasta has one large advantage: a string of world-class assets that could help it deliver sector-beating returns. This includes the Los Pelambres mine where it is steadily ramping up production.

The FTSE 100 firm now trades on a price-to-earnings (P/E) ratio of 35.6 times. A high figure such as this could cause a share price correction if news suddenly worsens. Yet on balance, I still believe it’s a top stock to consider owning for the next several years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

2 FTSE 100 high dividend shares to consider in May

I'm building a list of the best FTSE 100 income shares to buy this month. Here are two I'm expecting…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: Share Advisor’s latest lower-risk, higher-yield recommendation [PREMIUM PICKS]

Ice ideas will usually offer a steadier flow of income and is likely to be a slower-moving but more stable…

Read more »

Investing Articles

Here’s how I’d target passive income from FTSE 250 stocks right now

Dividend stocks aren't the only ones we can use to try to build up some long-term income. No, I like…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

If I put £10k in this FTSE 100 stock, it could pay me a £1,800 second income over the next 2 years

A FTSE 100 stock is carrying a mammoth 10% dividend yield and this writer reckons it could contribute towards an…

Read more »

Investing Articles

2 UK shares I’d sell in May… if I owned them

Stephen Wright would be willing to part with a couple of UK shares – but only because others look like…

Read more »

Investing Articles

2 FTSE 250 shares investors should consider for a £1,260 passive income in 2024

Investing a lump sum in these FTSE 250 shares could yield a four-figure dividend income this year. Are they too…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

This FTSE share has grown its decade annually for over 30 years. Can it continue?

Christopher Ruane looks at a FTSE 100 share that has raised its dividend annually for decades. He likes the business,…

Read more »

Elevated view over city of London skyline
Investing Articles

Few UK shares grew their dividend by 90% in 4 years. This one did!

Among UK shares, few have the recent track record of annual dividend increases to match this one. Our writer likes…

Read more »